Kou Qin joined Eisai Innovation, Inc. in 2021. Previously at MSA Capital, he was in charge of healthcare strategy and investment globally. Prior to that, he ran the corporate incubation program at BGI. He started Skinome, a skin disease diagnosis company, invested by Y …

G protein-coupled receptors (GPCRs) interact directly with heterotrimeric G proteins to transduce physiological signals. Early studies of this interaction concluded that GPCRs (R) and G proteins...

View who can give you a warm intro to Kou and 30,000+ top startup investors by joining Signal. See Kou Qin's recent investments in Seed Medical Devices, other investment areas, and co-investors.

2017年9月29日 · Kou Qin, general manager of Guardian Art Center and director of China Guardian, says the opening of the art center is China Guardian's attempt to diversify its art business to attract museums, art dealers, artists and art lovers, instead of only art buyers. "It shows our confidence in China's art market and cultural scene.

Check out professional insights posted by Kou Qin, PhD, Investment Director @ Eisai Innovation | Biotech Venture Capitalist

Kou Qin is the President and Chief Executive Officer of Guardian Investment Holdings, General Manager of Guardian Art Center, and Director of Guardian Education. He is one of the founding members of China Guardian Auctions and is a board member of China Guardian Auctions.

Kou Qin, PhD Investment Director @ Eisai Innovation | Biotech Venture Capitalist 4mo Report this post Science magazine's Breakthroughs of the Year: both the GLP-1 agonist for obesity treatment and ...

Musk Leaves Twitter Staff Without Equity Plan as Deadline LoomsRead Now. Org Charts Briefings About Video Events Partners

21 Followers, 20 Following, 12 Posts - See Instagram photos and videos from Kou Qin (@kouqin2020)